Global Porcine Vaccines Market Forecasted to Surge at an Impressive CAGR of 7.0% during 2017 – 2025

Worldwide, high prevalence and incidence rates of porcine epidemic diarrhea (PED), swine flu, and porcine reproductive and respiratory syndrome (PRRS) in swine production farms have resulted in the increase in early vaccination of piglets and adult pigs. Considering this, a new study finds that the demand for porcine vaccines has been increased. Market Research Hub (MRH) has added a latest study titled “Porcine Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” to its vast repository, which majorly aims to provide wide-ranging insights into the market current scenario and future growth prospects during the mentioned forecast period of 2017-2025. It also provides information and data analysis of the market with respect to segments based on disease indication, technology, end-user, and region.

Request here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1753274

Market Overview

A porcine vaccine is an administrative as well as clinical drug that helps in improving the health of swine and protects them from deadly viruses, bacteria, and pathogens. At present, the market for porcine vaccine has been growing due to rising investment by governments in the field of animal health care, high incidence of swine fever, increase in R&D expenses suffered for eradicating porcine health issues, and surge in the demand for porcine meat and gelatin.

In order to provide accurate results, the global market growth has been analyzed in terms of revenue and volume estimates (in US$ Mn and Thousand Units), across different geographies such as North America, Europe, Asia-Pacific, Middle East and Africa and Latin America. As per the study key findings, the global porcine vaccines market was valued at US$ 1,784.0 Mn in 2016 and is projected to expand at a (CAGR) of 7.0% from 2017 to 2025.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/porcine-vaccines-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html

Major Highlights from the Study

Presently, a surge in the number of trading facilities for live hogs/pigs, rise in the demand for pork meat, and innovations through clinical research activities are some of the prime factors expected to drive the global porcine vaccines market during the forecast period.
As mentioned earlier, based on market segmentation into technology, the global market has been categorized into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. In terms of disease indication, the report covers diarrhea, swine influenza, arthritis, Bordetella rhinitis, porcine reproductive and respiratory syndrome (PRRS), porcine circovirus associated disease (PCVAD), and others (CHRS, leptospirosis, etc.). In the study, the market size (in terms of US$ Mn) and forecast for each segment have been provided until 2025.

Geographically, North America and Europe are projected to dominate the global market during the forecast period. Among end-users, the hog production farms segment holds a major share, followed by the veterinary hospital's segment.
The last section comprises precise analysis of the companies’ active in the market, such as Bayer AG., Bimeda Animal Health, Vetoquinol, Ceva Santé Animale, Boehringer Ingelheim GmbH, Elanco (Eli Lilly and Company), Merck & Co., Inc., and Zoetis Inc.

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Vaccines industry research reports and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

ContactUs                                                                                                   

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com

This release was published on openPR.